Gary J. Kelloff

22.6k total citations · 3 hit papers
273 papers, 14.6k citations indexed

About

Gary J. Kelloff is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Gary J. Kelloff has authored 273 papers receiving a total of 14.6k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Molecular Biology, 82 papers in Genetics and 61 papers in Cancer Research. Recurrent topics in Gary J. Kelloff's work include Estrogen and related hormone effects (38 papers), Inflammatory mediators and NSAID effects (31 papers) and Genomics, phytochemicals, and oxidative stress (30 papers). Gary J. Kelloff is often cited by papers focused on Estrogen and related hormone effects (38 papers), Inflammatory mediators and NSAID effects (31 papers) and Genomics, phytochemicals, and oxidative stress (30 papers). Gary J. Kelloff collaborates with scholars based in United States, Canada and United Kingdom. Gary J. Kelloff's co-authors include Vernon E. Steele, Caroline C. Sigman, Ronald A. Lubet, Charles W. Boone, Chinthalapally V. Rao, James A. Crowell, Ernest T. Hawk, R Lubet, Clinton J. Grubbs and Vernon E. Steele and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Gary J. Kelloff

268 papers receiving 13.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer.

1999 513 citations R Lubet, Vernon E. Steele et al. profile →
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development

2005 499 citations Gary J. Kelloff, Bruce D. Cheson et al. profile →
Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia

2017 334 citations Howard R. Higley, Gary J. Kelloff et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gary J. Kelloff United States	65	6.3k	2.8k	2.7k	2.5k	2.1k	273	14.6k
Vernon E. Steele United States	57	5.7k 0.9×	2.1k 0.8×	1.9k 0.7×	2.8k 1.1×	2.1k 1.0×	293	11.9k
Ronald A. Lubet United States	57	5.4k 0.9×	3.0k 1.1×	2.2k 0.8×	2.7k 1.1×	2.3k 1.1×	344	12.7k
I. Bernard Weinstein United States	79	13.6k 2.2×	5.9k 2.1×	2.3k 0.9×	4.1k 1.7×	1.2k 0.6×	377	21.9k
Chinthalapally V. Rao United States	62	6.4k 1.0×	4.8k 1.7×	2.1k 0.8×	4.2k 1.7×	3.8k 1.8×	262	16.9k
Dominic A. Scudiero United States	50	16.3k 2.6×	6.2k 2.2×	1.4k 0.5×	3.3k 1.3×	2.9k 1.3×	95	28.1k
William P. Steward United Kingdom	67	7.4k 1.2×	4.3k 1.5×	635 0.2×	2.0k 0.8×	1.8k 0.8×	221	18.3k
Anne Monks United States	43	12.8k 2.0×	5.4k 1.9×	1.1k 0.4×	2.3k 0.9×	2.8k 1.3×	103	24.4k
Powel H. Brown United States	54	5.2k 0.8×	3.9k 1.4×	2.3k 0.8×	2.6k 1.1×	652 0.3×	223	10.1k
Ting‐Chao Chou United States	60	14.1k 2.2×	8.1k 2.8×	1.5k 0.6×	2.2k 0.9×	1.8k 0.8×	350	29.3k
Dean E. Brenner United States	53	6.1k 1.0×	3.2k 1.1×	615 0.2×	1.4k 0.6×	997 0.5×	182	14.6k

Countries citing papers authored by Gary J. Kelloff

Since Specialization

Citations

This map shows the geographic impact of Gary J. Kelloff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary J. Kelloff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary J. Kelloff more than expected).

Fields of papers citing papers by Gary J. Kelloff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary J. Kelloff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary J. Kelloff. The network helps show where Gary J. Kelloff may publish in the future.

Co-authorship network of co-authors of Gary J. Kelloff

This figure shows the co-authorship network connecting the top 25 collaborators of Gary J. Kelloff. A scholar is included among the top collaborators of Gary J. Kelloff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary J. Kelloff. Gary J. Kelloff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Williams, P. Mickey, Steven P. Lund, Kenneth D. Cole, et al.. (2021). Validation of ctDNA Quality Control Materials Through a Precompetitive Collaboration of the Foundation for the National Institutes of Health. JCO Precision Oncology. 5(5). 910–920. 14 indexed citations

Schöder, Heiko, Mei‐Yin C. Polley, Michael V. Knopp, et al.. (2020). Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial. Blood. 135(25). 2224–2234. 63 indexed citations

Menetski, Joseph P., John A. Wagner, Linda S. Brady, et al.. (2017). What evidence do we need for biomarker qualification?. Science Translational Medicine. 9(417). 45 indexed citations

Kelloff, Gary J. & Caroline C. Sigman. (2012). Cancer biomarkers: selecting the right drug for the right patient. Nature Reviews Drug Discovery. 11(3). 201–214. 185 indexed citations

Meyskens, Frank L., Gregory A. Curt, Dean E. Brenner, et al.. (2011). Regulatory Approval of Cancer Risk-Reducing (Chemopreventive) Drugs: Moving What We Have Learned into the Clinic. Cancer Prevention Research. 4(3). 311–323. 36 indexed citations

Meyskens, Frank L., Christine E. McLaren, Daniel Pelot, et al.. (2008). Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial. Cancer Prevention Research. 1(1). 32–38. 392 indexed citations

Kelloff, Gary J., Ernest T. Hawk, & Caroline C. Sigman. (2004). Promising cancer chemopreventive agents. Humana Press eBooks. 9 indexed citations

Kelloff, Gary J., Ernest T. Hawk, & Caroline C. Sigman. (2004). Cancer Chemoprevention. Humana Press eBooks. 14 indexed citations

D’Agostini, Francesco, Roumen Balansky, Carlo Bennicelli, et al.. (2001). Pilot studies evaluating the lung tumor yield in cigarette smoke-exposed mice. International Journal of Oncology. 18(3). 607–15. 42 indexed citations

10.

Kelloff, Gary J., James A. Crowell, Vernon E. Steele, et al.. (2000). Progress in Cancer Chemoprevention: Development of Diet-Derived Chemopreventive Agents. Journal of Nutrition. 130(2). 467S–471S. 382 indexed citations

11.

Li, Hong, Paula M. Kramer, Ronald A. Lubet, et al.. (1998). Effect of calcium on azoxymethane-induced aberrant crypt foci and cell proliferation in the colon of rats. Cancer Letters. 124(1). 39–46. 25 indexed citations

12.

Bacus, James W., et al.. (1997). Quantitation of preinvasive neoplastic progression in animal models of chemical carcinogenesis. Journal of Cellular Biochemistry. 67(S28-29). 21–38. 10 indexed citations

13.

Morse, Mark A., Laura A. Kresty, Vernon E. Steele, et al.. (1997). Effects of theaflavins onN‐nitrosomethylbenzylamine‐induced esophageal tumorigenesis. Nutrition and Cancer. 29(1). 7–12. 40 indexed citations

14.

Arif, Jamal M., C. Gary Gairola, Howard P. Glauert, et al.. (1997). Effects of dietary supplementation of N-acetylcysteine on cigarette smoke-related DNA adducts in rat tissues. International Journal of Oncology. 11(6). 1227–33. 12 indexed citations

15.

Kelloff, Gary J., et al.. (1993). Development of chemopreventive agents for lung and upper aerodigestive tract cancers. Journal of Cellular Biochemistry. 53(S17F). 2–17. 18 indexed citations

16.

Greenwald, Peter, et al.. (1993). Research Studies on Chemoprevention of Esophageal Cancer at the United States National Cancer Institute. Endoscopy. 25(9). 617–626. 2 indexed citations

17.

Malone, Winfred F., et al.. (1989). Chemoprevention and modern cancer prevention. Preventive Medicine. 18(5). 553–561. 19 indexed citations

18.

Malone, Winfred F., et al.. (1987). Chemoprevention of bladder cancer. Cancer. 60(S3). 650–657. 36 indexed citations

19.

Sass, Bernard, Robert L. Peters, & Gary J. Kelloff. (1976). Differences in tumor incidence in two substrains of Claude BALB/c (BALB/cfCd) mice, emphasizing renal, mammary, pancreatic, and synovial tumors.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 26(5). 736–41. 5 indexed citations

20.

Hampar, Berge, Gary J. Kelloff, Lidia M. Martos, et al.. (1970). Replication of Murine and Feline RNA-containing C-type Viruses in Human Lymphoblastoid Cells. Nature. 228(5274). 857–859. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact